Transcriptional activation of the urokinase receptor gene by endothelin-1

Biochem Biophys Res Commun. 1992 Aug 14;186(3):1631-8. doi: 10.1016/s0006-291x(05)81595-5.

Abstract

Using an immortalized human glomerular epithelial cell line (E71 A1), we studied the effect of endothelin-1 (ET-1), a potent vasoconstrictor peptide, on the synthesis of urokinase type plasminogen activator (u-PA) and its receptor (u-PAR). The results show that ET-1 had no effect on u-PA synthesis but induced an increase in u-PAR number (2.8 +/- 0.6 x 10(4) vs 1.2 +/- 0.5 x 10(4) sites per cell, p less than 0.001) without change in receptor affinity (280 +/- 80 pM vs 250 +/- 50 pM, NS), maximal effect being observed at 10(-7) M. Time course shows that a plateau was reached after a 24 hour incubation. ET-1 induced-increase in binding capacity was abolished by cycloheximide. ET-1 also induced an increase in u-PAR mRNA level, which was completely blocked by alpha-amanitin (5 micrograms/ml). Cycloheximide (1 microgram/ml) alone induced an increase in u-PAR mRNA level and this effect was enhanced when cycloheximide was combined with ET-1. Our data show that ET-1 can induce an increase in membrane expression of u-PAR through activation of the transcription of the u-PAR gene and de novo protein synthesis.

MeSH terms

  • Amanitins / pharmacology
  • Cell Line
  • Cell Membrane / metabolism
  • Cycloheximide / pharmacology
  • Endothelins / physiology*
  • Gene Expression Regulation / drug effects
  • Gene Expression Regulation / physiology*
  • Humans
  • Kidney Glomerulus / metabolism
  • RNA, Messenger / genetics
  • Receptors, Cell Surface / genetics*
  • Receptors, Urokinase Plasminogen Activator
  • Transcription, Genetic / physiology
  • Urokinase-Type Plasminogen Activator / metabolism*

Substances

  • Amanitins
  • Endothelins
  • PLAUR protein, human
  • RNA, Messenger
  • Receptors, Cell Surface
  • Receptors, Urokinase Plasminogen Activator
  • Cycloheximide
  • Urokinase-Type Plasminogen Activator